CVS Health Corp (CVS) Stock Forecast & Price Target
CVS Health Corp · NYSE
$96.08-0.66 (-0.68%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering CVS Health Corp, 17 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $94.00 to $126.00, so the covering firms are broadly aligned. The average target of $112.50 sits 17% above the current $96.08. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.29 next quarter toward $8.51 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Strong Buy
Strong Buy00%
Buy17100%
Hold00%
Sell00%
Strong Sell00%
Based on 17 analysts giving stock ratings to CVS Health Corp.
As of Sep, 17 of 17 firms rate CVS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CVS EPS & revenue forecast
EPS · NEXT QUARTER
$1.29
Range $1.15 – $1.48 · 22 analysts · +19% YoY
Next period, 22 analysts expect CVS Health Corp to earn $1.29 a share (range $1.15 – $1.48), versus $1.09 a year earlier. Full-year consensus is $7.97, growing to $8.51 the year after.
REVENUE · NEXT QUARTER
$107.0B
Range $104.1B – $111.8B · 22 analysts · +1% YoY
Revenue is expected to reach $107.0B (range $104.1B – $111.8B), +1.2% year-over-year. Full-year consensus is $417.6B, rising to $429.3B next year.
Top analysts covering CVS Health Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CVS.
#1
Erin Wright
Morgan Stanley · Rank #36
Buy
$111.00+15.5% to target
Overall win rate
59%
+ Follow
#2
DM
David Macdonald
Truist Securities · Rank #109
Buy
$118.00+22.8% to target
Overall win rate
48%
+ Follow
#3
Ben Hendrix
RBC Capital · Rank #149
Buy
$113.00+17.6% to target
Overall win rate
44%
+ Follow
#4
Brian Tanquilut
Jefferies · Rank #208
Buy
$80.00-16.7% to target
Overall win rate
42%
+ Follow
#5
LW
Lance Wilkes
Bernstein
Buy
$106.00+10.3% to target
Coverage
—
+ Follow
CVS stock forecast FAQ
What is CVS's average 12-month price target?+
The 16 analysts with a live target average $112.50 for CVS Health Corp over the next 12 months, ranging from a $126.00 high to a $94.00 low.
Is CVS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 17 analyst ratings, 17 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CVS?+
The Street-high target is $126.00 (UBS), and the Street-low is $94.00 (Baird). The average of all 16 active targets is $112.50.
How many Wall Street analysts cover CVS?+
17 analysts have an active rating on CVS Health Corp, and 16 firms carry a live 12-month price target.
Who is the most accurate analyst covering CVS?+
Among analysts who currently cover CVS, Erin Wright of Morgan Stanley has the strongest overall Quantellect track record (Rank #36). Their current call is Buy with a $111.00 target.
What is CVS Health Corp's projected EPS for next quarter?+
The consensus estimate is $1.29 per share (range $1.15 – $1.48) across 22 analysts. Full-year EPS is projected at $7.97, rising to $8.51 the following year.
How much revenue is CVS Health Corp expected to report next quarter?+
Consensus revenue is $107.0B (range $104.1B – $111.8B). Full-year revenue is projected at $417.6B, growing to $429.3B next year.
Have analysts been upgrading or downgrading CVS lately?+
As of Sep, 17 of 17 firms rate CVS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
